Biogen Inc. beat EPS estimates 100% of the time across 2 reported quarters (2 beats, 0 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $3.13 | — | — | Miss |
| Q12026 FY2026 | $2.95 | $3.57 | +21.0% | Beat |
| Q42025 FY2025 | $1.61 | $1.99 | +23.6% | Beat |
Back to BIIB overview · BIIB holders · BIIB KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.